Does CAPTOPRIL Cause Interstitial lung disease? 11 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Interstitial lung disease have been filed in association with CAPTOPRIL (Captopril). This represents 1.0% of all adverse event reports for CAPTOPRIL.
11
Reports of Interstitial lung disease with CAPTOPRIL
1.0%
of all CAPTOPRIL reports
1
Deaths
11
Hospitalizations
How Dangerous Is Interstitial lung disease From CAPTOPRIL?
Of the 11 reports, 1 (9.1%) resulted in death, 11 (100.0%) required hospitalization.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CAPTOPRIL. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does CAPTOPRIL Cause?
Drug ineffective (122)
Hypotension (97)
Hypertension (96)
Nausea (86)
Condition aggravated (85)
Dyspnoea (78)
Drug hypersensitivity (70)
Diarrhoea (68)
Acute kidney injury (62)
Asthenia (57)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CAPTOPRIL Alternatives Have Lower Interstitial lung disease Risk?
CAPTOPRIL vs CARBAMAZEPINE
CAPTOPRIL vs CARBETOCIN
CAPTOPRIL vs CARBIDOPA
CAPTOPRIL vs CARBIDOPA\ENTACAPONE\LEVODOPA
CAPTOPRIL vs CARBIDOPA\LEVODOPA